DENTSPLY SIRONA Inc
NASDAQ:XRAY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.89
20.31
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc., a leading figure in the dental industry, has crafted a compelling narrative of innovation and strategic growth since its inception. The roots of this global dental solutions company can be traced back to the merger of DENTSPLY International and Sirona Dental Systems in 2016. This fusion combined strengths in dental consumables and cutting-edge equipment, creating a formidable presence in the dental market. Headquartered in Charlotte, North Carolina, with operations spanning the globe, DENTSPLY SIRONA is renowned for its comprehensive suite of dental solutions. From dental instruments and restorative materials to high-tech imaging systems and digital dental equipment, the company is at the forefront of providing holistic solutions for dental professionals. Its product line is meticulously designed to enhance clinical outcomes, improve patient experiences, and support the evolving needs of dental practices worldwide.
Central to DENTSPLY SIRONA's business model is its relentless commitment to research and development, which fuels its aggressive innovations and product enhancements. This dedication to cutting-edge technology and quality assurance underpins the company's revenue streams, primarily derived from its diverse range of product segments. These encompass consumables, dental technology, and equipment solutions, which are marketed directly to dental professionals and through distributors. By capitalizing on its expansive distribution network and strategic partnerships, DENTSPLY SIRONA maintains a robust pipeline of products, ensuring steady demand and consistent economic performance in a rapidly advancing, innovation-driven industry. Through strategic acquisitions, global expansion, and a focus on education and training for dental professionals, the company continues to solidify its market position while driving forward the evolution of dental care.
DENTSPLY SIRONA Inc., a leading figure in the dental industry, has crafted a compelling narrative of innovation and strategic growth since its inception. The roots of this global dental solutions company can be traced back to the merger of DENTSPLY International and Sirona Dental Systems in 2016. This fusion combined strengths in dental consumables and cutting-edge equipment, creating a formidable presence in the dental market. Headquartered in Charlotte, North Carolina, with operations spanning the globe, DENTSPLY SIRONA is renowned for its comprehensive suite of dental solutions. From dental instruments and restorative materials to high-tech imaging systems and digital dental equipment, the company is at the forefront of providing holistic solutions for dental professionals. Its product line is meticulously designed to enhance clinical outcomes, improve patient experiences, and support the evolving needs of dental practices worldwide.
Central to DENTSPLY SIRONA's business model is its relentless commitment to research and development, which fuels its aggressive innovations and product enhancements. This dedication to cutting-edge technology and quality assurance underpins the company's revenue streams, primarily derived from its diverse range of product segments. These encompass consumables, dental technology, and equipment solutions, which are marketed directly to dental professionals and through distributors. By capitalizing on its expansive distribution network and strategic partnerships, DENTSPLY SIRONA maintains a robust pipeline of products, ensuring steady demand and consistent economic performance in a rapidly advancing, innovation-driven industry. Through strategic acquisitions, global expansion, and a focus on education and training for dental professionals, the company continues to solidify its market position while driving forward the evolution of dental care.
Sales Decline: Q3 2025 global sales fell to $904 million, down 5% as reported and negative 8% on a constant currency basis.
Profit Pressure: Adjusted EBITDA margin rose 50 basis points, but EPS dropped by $0.13 to $0.37, mainly due to sales mix, tariffs, and a higher tax rate.
U.S. Weakness: U.S. sales were especially soft, down 22.2% year-over-year, or 9.7% when adjusting for one-offs.
Guidance Lowered: Full-year 2025 sales guidance was cut to $3.6–$3.7 billion and EPS to about $1.60; sales are now expected to decline 4–5% in constant currency.
Leadership Change: CFO Matt Garth has left; a transition plan is in place while a search for a successor is underway.
Growth Action Plan: New CEO outlined a multi-pillar 'Return to Growth' strategy focusing on customer centricity, reigniting U.S. performance, empowering people, and operational improvements.
Increased R&D Investment: The company is accelerating R&D spending into Q4 to position for growth in 2026 and beyond.
